The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women.
Study Type
INTERVENTIONAL
2000 mg of inositol+200mcg of folic acid; 2 per diem
600 mg of inositol + 200mcg of folic acid; 2 cp per diem
Folic Acid 400mcg; 1 cp/die
AGUNCO
Rome, Italy
RECRUITINGOGTT
The diagnostic 75g oral glucose tolerance test (OGTT) is performed between 24 and 28 weeks of gestation.
Number of pregnant women with gestational diabetes
Number of pregnant women requiring insulin treatment
Weight gain at the end of pregnancy
Number of newborn infants whose weight is more than 4000 g
Number of newborn infants requiring Neonatal Intensive Care (NIC)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.